| Serial Number | 88981530 |
| Word Mark | CENTER FOR BREAKTHROUGH MEDICINES |
| Filing Date | Thursday, December 12, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 8, 2021 |
| Registration Number | 6382057 |
| Registration Date | Tuesday, June 8, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 12, 2021 |
| Goods and Services | Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting |
| Disclaimer with Predetermined Text | "CENTER" AND "MEDICINES" |
| Goods and Services | Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 16, 2019 |
| Primary Code | 040 |
| First Use Anywhere Date | Tuesday, March 16, 2021 |
| First Use In Commerce Date | Tuesday, March 16, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 16, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, March 16, 2021 |
| First Use In Commerce Date | Tuesday, March 16, 2021 |
| Party Name | CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | KING OF PRUSSIA, PA 19406 |
| Party Name | MORNING LIGHT IP, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Radnor, PA 19087 |
| Party Name | MORNING LIGHT IP, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Radnor, PA 19087 |
| Party Name | MORNING LIGHT IP, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Radnor, PA 19087 |
| Event Date | Event Description |
| Wednesday, October 19, 2022 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, June 8, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, May 6, 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, May 5, 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, May 3, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, April 5, 2021 | USE AMENDMENT FILED |
| Monday, May 3, 2021 | DIVISIONAL PROCESSING COMPLETE |
| Monday, April 5, 2021 | DIVISIONAL REQUEST RECEIVED |
| Monday, April 26, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, April 5, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Monday, April 5, 2021 | TEAS REQUEST TO DIVIDE RECEIVED |
| Tuesday, March 9, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 12, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 12, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 23, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 8, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, December 7, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 7, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 7, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 30, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 30, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 30, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, June 26, 2020 | ASSIGNED TO EXAMINER |
| Friday, June 26, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, May 12, 2020 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Tuesday, April 28, 2020 | ASSIGNED TO LIE |
| Wednesday, April 22, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 22, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 21, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 21, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 16, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 16, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, March 16, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, March 12, 2020 | ASSIGNED TO EXAMINER |
| Monday, December 16, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, December 16, 2019 | NEW APPLICATION ENTERED IN TRAM |